tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Stock Investors

59 Followers
Based on 734,331 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NAMS
On average, investors allocate 0.00% of their portfolios to NAMS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 734,331 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NAMS

1.3%
Last 7
Days
0.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NAMS, out of 734,331 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NAMS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.01%
$23.05
Opened
0.31%
$22.03
Based on the activity of 13,827 investors who made their portfolios public
The table shows changes in NAMS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NAMS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.64%
-0.28%
-0.08%
44.14B
Technology
Coherus Biosciences
2.60%
-0.84%
-5.66%
250.10M
Healthcare
CVS Health
3.89%
-0.11%
+1.55%
70.63B
Healthcare
ServiceNow
3.88%
+0.29%
+4.05%
155.92B
Technology
UnitedHealth
4.66%
-0.06%
-0.51%
476.35B
Healthcare
Delta Air Lines
5.61%
-0.69%
-1.45%
34.37B
Industrials
Oracle
4.25%
+0.24%
+0.17%
334.30B
Technology
Novo Nordisk
5.48%
+0.33%
+3.46%
593.42B
Healthcare
Micron
5.76%
+0.03%
+1.98%
141.53B
Technology
Mercadolibre
5.53%
-0.31%
+0.56%
87.12B
Consumer Cyclical
Based on the activity of 734,331 active portfolios
Open your Smart Portfolio

NAMS Investor Analysis

NAMS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.1%
of NAMS holders
are under 35
Average Segment Performance
Average P/E Ratio20.00
Beta6.11
Dividend Yield5.28%
NAMS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
90.9%
of NAMS holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.45
Beta10.75
Dividend Yield18.14%
NAMS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
0.0%
of NAMS holders
are over 55
Average Segment Performance
Average P/E Ratio18.60
Beta3.83
Dividend Yield6.02%
Overview of age group and performance of NAMS stock investors
See who invests in NAMS according to age group and performance.

FAQ

How many retail Investors hold NAMS?
<0.1% of TipRanks' retail investors hold NAMS in their portfolios.
    What is NAMS Investor Sentiment?
    NAMS’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of NAMS in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of NAMS in the last 7 days.
        What percentage of retail investors changed their holding of NAMS in the last 30 days?
        ▲ 0.2% of TipRanks' retail investors changed their holding of NAMS in the last 30 days.
          What is the average age of retail investors who hold NAMS?
          The average age of NAMS Holders is between 35–55.
            What other stocks have NAMS investors also bought?
            NAMS Investors also bought TTD, CHRS, CVS, NOW, UNH, DAL, ORCL, NVO, MU, MELI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALKSAlkermes
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis